首页> 外文期刊>British journal of nursing: BJN >Management of patients who have relapses in multiple sclerosis.
【24h】

Management of patients who have relapses in multiple sclerosis.

机译:多发性硬化症复发患者的管理。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Multiple sclerosis (MS) is a chronic neurological condition, which disrupts the typical functions and daily activities of those affected. Approximately 80% of those diagnosed will follow a relapsing/remitting disease course at diagnosis. Patients with relapsing/remitting MS can expect to have episodes of relapse or an exacerbation of the disease and its variety of symptoms. Management of such episodes has always been open to the preferences of the healthcare professionals involved. The aim of this article is to review the evidence that exists to support current practice in the management of patients during a relapse and to evaluate how this evidence can be incorporated into patient care. The article begins by giving an overview of MS, and continues by determining what a relapse is and discussing the speculated triggers of relapse. Methods of treating relapse are then explored. It concludes by highlighting the strongest evidence-based method for treating relapses, and by emphasizing the need for furtherresearch into the pharmaceutical and non-pharmaceutical management of MS relapses.
机译:多发性硬化症(MS)是一种慢性神经系统疾病,会破坏受影响者的典型功能和日常活动。大约80%的被诊断者将在诊断时遵循复发/缓解疾病的过程。 MS复发/缓解的患者可能会出现复发发作或疾病及其各种症状加重。此类事件的管理始终向所涉及的医疗保健专业人员开放。本文的目的是回顾现有证据,以支持当前复发患者管理中的实践,并评估如何将该证据纳入患者护理。本文首先概述了MS,然后继续确定什么是复发并讨论了推测的复发触发因素。然后探讨治疗复发的方法。最后,重点介绍了用于治疗复发的最有力的循证医学方法,并强调了需要进一步研究MS复发的药物和非药物治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号